BNP Paribas Financial Markets Adds $16M in Aflac Incorporated ($AFL)
Key Points
- BNP Paribas Financial Markets changed its Aflac Incorporated ($AFL) stake by 18.6% last quarter, boosting to 870,926 shares worth $101.79 million.
- Wall Street's consensus rating on $AFL is Hold and an average price target of $112.43.
- $AFL last traded around $116.88.
BNP Paribas Financial Markets increased its position in Aflac Incorporated ($AFL) by 18.6% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 870,926 shares of Aflac Incorporated after buying 136,739 shares during the quarter. BNP Paribas Financial Markets's holdings in Aflac Incorporated were worth $101.79 million as of its most recent filing.
Aflac Incorporated ($AFL) Stock
Aflac Incorporated Earnings
Aflac Incorporated Dividend
Analysts Set New Price Targets
About Aflac Incorporated
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.